<!DOCTYPE html><html><head><link href='https://fonts.googleapis.com/css?family=Spectral' rel='stylesheet'><style>body {    font-family: 'Spectral';font-size: 14px;}</style></head><body><b>Search Term: </b>"cystic fibrosis" AND ("gene therapy" OR "genome editing" OR "mRNA therapy")<br><b>Date run: </b>2020/01/05<br><br><h2>PubMed Articles</h2> <br><br><b><a href="https://ncbi.nlm.nih.gov/pubmed/31391465">Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing.</a></b><br><b>Journal:</b> Nat Commun<br><b>Two-year IF:</b> 11.80<br><br><b><a href="https://ncbi.nlm.nih.gov/pubmed/31864360">Gene therapy-emulating small molecule treatments in cystic fibrosis airway epithelial cells and patients.</a></b><br><b>Journal:</b> Respir. Res.<br><b>Two-year IF:</b> 3.89<br><br><b><a href="https://ncbi.nlm.nih.gov/pubmed/31781503">Therapeutic Prospects of mRNA-Based Gene Therapy for Glioblastoma.</a></b><br><b>Journal:</b> Front Oncol<br><b>Two-year IF:</b> 4.25<br><br><b><a href="https://alexmakijokela.github.io/202001051816_cysticfibrosisandgenetherapyorgenomeeditingormrnatherapy.html#pubmed">More Results...</a></b><br><br><h2>Companies</h2> <br><br><b><a href="https://www.linkedin.com/company/crispr-therapeutics/about/">CRISPR Therapeutics</a></b><br><br><b><a href="https://www.linkedin.com/company/orchard-therapeutics/about/">Orchard Therapeutics</a></b><br><br><b><a href="https://www.linkedin.com/company/trucode-gene-repair-inc/about/">Trucode Gene Repair, Inc.</a></b><br><br><b><a href="https://alexmakijokela.github.io/202001051816_cysticfibrosisandgenetherapyorgenomeeditingormrnatherapy.html#companies">More Results...</a></b><br><br><h2>Patents</h2> <br><br><b><a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=33&p=1&f=G&l=50&d=PTXT&S1=(%22cystic+fibrosis%22+AND+((%22gene+therapy%22+OR+%22genome+editing%22)+OR+%22mRNA+therapy%22))&OS="cystic+fibrosis"+AND+("gene+therapy"+OR+"genome+editing"+OR+"mRNA+therapy")&RS=("cystic+fibrosis"+AND+(("gene+therapy"+OR+"genome+editing")+OR+"mRNA+therapy"))">Regulation of gene expression by aptamer-mediated modulation of alternative splicing</a></b><br><b>Patent date:</b> December 3, 2019<br><br><b><a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=34&p=1&f=G&l=50&d=PTXT&S1=(%22cystic+fibrosis%22+AND+((%22gene+therapy%22+OR+%22genome+editing%22)+OR+%22mRNA+therapy%22))&OS="cystic+fibrosis"+AND+("gene+therapy"+OR+"genome+editing"+OR+"mRNA+therapy")&RS=("cystic+fibrosis"+AND+(("gene+therapy"+OR+"genome+editing")+OR+"mRNA+therapy"))">Effective delivery of large genes by dual AAV vectors</a></b><br><b>Patent date:</b> December 3, 2019<br><br><b><a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=32&p=1&f=G&l=50&d=PTXT&S1=(%22cystic+fibrosis%22+AND+((%22gene+therapy%22+OR+%22genome+editing%22)+OR+%22mRNA+therapy%22))&OS="cystic+fibrosis"+AND+("gene+therapy"+OR+"genome+editing"+OR+"mRNA+therapy")&RS=("cystic+fibrosis"+AND+(("gene+therapy"+OR+"genome+editing")+OR+"mRNA+therapy"))">Delivery methods and compositions for nuclease-mediated genome engineering</a></b><br><b>Patent date:</b> December 3, 2019<br><br><b><a href="https://alexmakijokela.github.io/202001051816_cysticfibrosisandgenetherapyorgenomeeditingormrnatherapy.html#patents">More Results...</a></b><br><br><br><b><a href="https://alexmakijokela.github.io/202001051816_cysticfibrosisandgenetherapyorgenomeeditingormrnatherapy.html">Link to Full Search Results</a></b><br></body></html>